Key result
Selective 5-HT4 receptor blockade with SB203186 initially protected porcine atria against ERP and MAP shortening during AF, but the effect diminished over 6 hours and 4 pigs developed tachycardia.
Why the study?
Does 5-HT4 receptor blockade or stimulation alter atrial electrophysiological parameters during 6 hours of atrial fibrillation in a porcine model?
Does 5-HT4 receptor blockade or stimulation alter atrial electrophysiological parameters during 6 hours of atrial fibrillation in a porcine model?
5-HT4 receptor blockade initially protects against atrial electrophysiological remodeling during short periods of AF in pigs, but this effect diminishes over 6 hours and may promote atrial tachycardia.
Transient protection with tachycardia risk in pigs cautions against clinical translation; leaves open human efficacy in sustained AF.
AIMS: Stimulation of atrial 5-HT4 receptors is associated with arrhythmias. Their blockade prolongs atrial effective refractory period (ERP), following short runs of atrial fibrillation (AF). The role of 5-HT4 receptors during longer periods of AF is unknown. In this study, we investigated the effects of the selective 5-HT4 receptor stimulation and blockade on porcine atria, during 6 h of AF. METHODS: Atrial ERP, monophasic action potential (MAP) duration, time to sinus rhythm restoration (TSRR) and ERP/MAP ratio were assessed in 27 pigs, at baseline and every hour, during 6 h of AF, induced by rapid atrial pacing. Ten animals were used as controls, 10 were administered the selective 5-HT4 antagonist SB203186 and seven were administered the selective 5-HT4 agonist RS67333. RESULTS: During the first few hours of fibrillation, ERP, MAP and TSRR were preserved in SB203186-treated pigs, while they were shortened in controls and RS67333-treated animals. After 6 h of arrhythmia, ERP and MAP were shortened in all three groups, but the decrease was less in SB203186-treated pigs. ERP/MAP ratio increased in controls and RS67333-treated animals, while it remained unchanged in SB203186-treated pigs. Towards the end of the AF period, four of the SB203186-treated pigs developed sustained atrial tachycardia. CONCLUSION: Following short periods of AF, 5-HT4 receptors' blockade protects the porcine atria against ERP and MAP shortening, while their stimulation has the opposite result. This beneficial effect, though, is gradually diminished following longer periods of AF and atrial tachycardia may develop.
No takes yet. Share an insight, caveat, or question.
Leftheriotis et al. (2005) studied Atrial fibrillation (n=27). SB203186 (5-HT4 antagonist) and RS67333 (5-HT4 agonist) vs. Control was evaluated on Atrial effective refractory period (ERP), monophasic action potential (MAP) duration, time to sinus rhythm restoration (TSRR) and ERP/MAP ratio. Selective 5-HT4 receptor blockade with SB203186 initially protected porcine atria against ERP and MAP shortening during AF, but the effect diminished over 6 hours and 4 pigs developed tachycardia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: